Shenzhen Sine Electric (688395.SH) net profit in 2024 decreased by 26.67% year-on-year to 37.48 million yuan.
Sine Electric (688395.SH) released its 2024 annual performance report, reporting that during the reporting period, the company achieved operating income...
Shenzhen Sine Electric (688395.SH) released its 2024 annual performance report. During the reporting period, the company achieved operating income of 366 million yuan, a decrease of 1.98% compared to the same period last year; net profit attributable to the owners of the parent company was 37.4882 million yuan, a decrease of 26.67% compared to the same period last year.
During the reporting period, the company's operating income slightly decreased year-on-year, mainly due to a decrease in revenue from the logistics and construction machinery industries. Profit-related indicators decreased significantly year-on-year, mainly for the following reasons: first, the company expanded its sales team and increased sales personnel, leading to an increase in sales expenses; second, after acquiring Tenghe Precision Motor (Suzhou) Co., Ltd., the company's audit, legal, and other service expenses increased, and additional management personnel were hired, leading to an increase in management expenses; third, the company continued to innovate in products and technology, increasing the number of related research and development personnel, leading to an increase in research and development expenses; these factors combined to reduce the company's profit.
Related Articles

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.
SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


